Capricorn Fund Managers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Capricorn Fund Managers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-44,099	Closed	-$3.36M	–	116
2023 Q1	$3.36M	Sell	44,099 -33,343	-43%	-$2.77M	1.03%	37
2022 Q4	$6.43M	Buy	77,442 +22,442	+41%	+$1.82M	1.65%	19
2022 Q3	$4.36M	Buy	55,000 +39,000	+244%	+$3.29M	1.37%	18
2022 Q2	$1.19M	Buy	+16,000	New	+$1.2M	0.22%	72

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Capricorn Fund Managers's XBI Position: Q2 2023 in Review

Capricorn Fund Managers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 44,099 shares — an estimated $3.36M sold.

Capricorn Fund Managers first reported a position in XBI in Q2 2022 and held it in 4 quarters. The position peaked at $6.43M in Q4 2022. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Capricorn Fund Managers reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Capricorn Fund Managers sold 44,099 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $3.36M.
Capricorn Fund Managers first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 4 quarters.
Capricorn Fund Managers's State Street SPDR S&P Biotech ETF position peaked at $6.43M in Q4 2022.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Capricorn Fund Managers's 13F filing for Q2 2023, filed 12 Jul 2023.